|
ECB--23180630
Papers associated with LOC115919910 (and LOC590852)
???pagination.result.count???
???pagination.result.page??? 1
| Sort Newest To Oldest | Sort Oldest To Newest |
Potential use of compounds from sea cucumbers as MDM2 and CXCR4 inhibitors to control cancer cell growth., Wargasetia TL, Permana S, Widodo N., Exp Ther Med. October 1, 2018; 16 (4): 2985-2991.  |
|
Mechanism of Action and Applications of Interleukin 24 in Immunotherapy., Persaud L, De Jesus D, Brannigan O, Richiez-Paredes M, Huaman J, Alvarado G, Riker L, Mendez G, Dejoie J, Sauane M., Int J Mol Sci. June 2, 2016; 17 (6):  |
|
IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms., de Melo Campos P, Machado-Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, da Silva Souza Duarte A, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Olalla Saad ST, Traina F., Oncotarget. February 9, 2016; 7 (6): 6948-59.  |
|
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells., Machado-Neto JA, de Melo Campos P, Favaro P, Lazarini M, da Silva Santos Duarte A, Lorand-Metze I, Costa FF, Saad ST, Traina F., Oncotarget. October 6, 2015; 6 (30): 29573-84.  |
|
Anti-pancreatic cancer effects of a polar extract from the edible sea cucumber, Cucumaria frondosa., Roginsky AB, Ding XZ, Woodward C, Ujiki MB, Singh B, Bell RH, Collin P, Adrian TE., Pancreas. July 1, 2010; 39 (5): 646-52. |
???pagination.result.page??? 1